These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 3884286

  • 1. Oral propafenone in the suppression of chronic stable ventricular arrhythmias.
    Schamroth L, Myburgh DP, Schamroth CL, Scholtz ME, Pincus DR, Kawalsky DL.
    Chest; 1985 Apr; 87(4):448-51. PubMed ID: 3884286
    [Abstract] [Full Text] [Related]

  • 2. Effect of propafenone in patients with stable ventricular arrhythmias.
    de Soyza N, Terry L, Murphy ML, Thompson CH, Doherty JE, Sakhaii M, Dinh H.
    Am Heart J; 1984 Aug; 108(2):285-9. PubMed ID: 6380253
    [Abstract] [Full Text] [Related]

  • 3. Propafenone for the treatment of refractory complex ventricular ectopic activity.
    Hammill SC, Sorenson PB, Wood DL, Sugrue DD, Osborn MJ, Gersh BJ, Holmes DR.
    Mayo Clin Proc; 1986 Feb; 61(2):98-103. PubMed ID: 3945115
    [Abstract] [Full Text] [Related]

  • 4. [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment].
    Garimoldi M, Sghirinzetti M, Pirastu A, Cappiello E, Sala R, Terranova P.
    G Ital Cardiol; 1986 Apr; 16(4):328-32. PubMed ID: 2427383
    [Abstract] [Full Text] [Related]

  • 5. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P, Leclercq JF, Assayag P.
    Am J Cardiol; 1984 Nov 14; 54(9):60D-66D. PubMed ID: 6208770
    [Abstract] [Full Text] [Related]

  • 6. Holter monitoring comparative assessment of propafenone and dihydroquinidine efficacy in the treatment of premature ventricular beats.
    Rizzon P, De Toma L, Mangini SG, Scrutinio D, Lagioia R, De Nicolò M.
    Cardiologia; 1983 Sep 14; 28(9):791-801. PubMed ID: 6398703
    [No Abstract] [Full Text] [Related]

  • 7. [Anti-arrhythmic effects of propafenone in coronary patients with ventricular arrhythmias].
    Fiol M, Palma JL, Bayés de Luna A, Aza V, Sadurní J.
    Rev Esp Cardiol; 1984 Sep 14; 37(3):196-200. PubMed ID: 6505351
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Propafenone: a new agent for ventricular arrhythmia.
    Podrid PJ, Lown B.
    J Am Coll Cardiol; 1984 Jul 14; 4(1):117-25. PubMed ID: 6376591
    [Abstract] [Full Text] [Related]

  • 12. [Efficacy of propafenone in the treatment of ventricular hyperkinetic arrhythmias in subjects with a history of myocardial infarction].
    Zoni Berisso M, Carratino L, De Caro E, Ferroni A, Vecchio C.
    G Ital Cardiol; 1987 Mar 14; 17(3):233-8. PubMed ID: 3301504
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
    Naccarella F, Palmieri M, del Corso P, Lombardi G, Bracchetti D.
    Arzneimittelforschung; 1982 Mar 14; 32(5):547-50. PubMed ID: 7201833
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Double-blind placebo-controlled evaluation of propafenone in suppressing ventricular ectopic activity.
    Hodges M, Salerno D, Granrud G.
    Am J Cardiol; 1984 Nov 14; 54(9):45D-50D. PubMed ID: 6388303
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.